Final oxidation product of purine metabolism. Elevated levels cause urate crystal deposition in joints (gout) and the renal tract (nephrolithiasis).
| Sex | Age | Range | Notes |
|---|---|---|---|
| Female | ≥ 18 yrs | 140 – 360 | Adult female; rises post-menopause |
| Male | ≥ 18 yrs | 200 – 430 | Adult male |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.